Genomtec - Model ID - Mobile Platform for Genetic Diagnostics
Genomtec ID is a flagship technological solution currently under development, which will offer patients ultrafast mobile genetic diagnosis utilizing SNAAT®. The Genomtec ID platform makes it possible to run a diagnostic process at point of care, i.e., public clinics, consulting rooms, hospital, pharmacies and emergency wards, without the need of complicated and time-consuming handling by skilled personnel in the laboratory.
The platform includes an analyzer and reaction card with integrated genetic tests and provides multiplexing capability of up to five genetic targets at the same time. SARS-CoV-2 will be included in one of the Genomtec ID’s diagnostic panels intended for identification of respiratory diseases.
Currently, the Genomtec ID platform is at the industrialization stage in collaboration with the international CDMO partner in order to prepare the system for mass production. The manufacturable version of the microfluidic card is in its final stage of development. It is being created using injection moulding technology resulting from the experience of the German company, Microfluidic ChipShop.
It is expected that the POC molecular diagnostic industry will increase by approx. 14% CAGR by 2024, while the POC molecular diagnostic market is expected to be valued at USD 3.9 billion in 2024.
Nowadays, molecular diagnostics requires the user to know how to handle diagnostic equipment and how to correctly prepare the sample. SNAAT® combines mobility with incredible ease of use. The intuitive and simple diagnostic platform can be handled by health care professionals with no laboratory training, i.e., nurse, doctor, paramedic.
Specificity
Up to 100%
Sensitivity
Up to 100%
Speed
Time from sample to result
– as quickly as 15 min
Groundbreaking ease of use
You only need to apply a single drop of biological material, the test does not require prior sample preparation
Wide range of applications
The analyzer may be used by health care professionals, including GPs, pediatricians, gynecologists, nurses and paramedics
Extreme cost-effectiveness
Cost-effectiveness per test is comparable to other available technologies
Multiplexing
Up to 5 targets during 1 test
Global database
In the future, the analyzers shall provide anonymous information on the global outbreaks of individual diseases.
1 Sample the biological material
2 Apply the biological material into the reaction card
3 Place the reaction card in the device
4 Start the test
5 Test results available as quickly as 15 minutes